Hemel Hempstead, United Kingdom

Bespak Europe Limited


USPTO Granted Patents = 5



Trademarks = 2

Forward Citations = 13

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Martin John McLoughlin (3 out of 31 patents)

silverMedal Matt Ekman (3 out of 3 patents)

bronzeMedal Ian Anderson (2 out of 17 patents)

4.  Ian Darnell (2 out of 5 patents)

5.  Neil Bentley Cammish (2 out of 6 patents)

6.  Barry Alan Knight (1 out of 12 patents)

7.  Deborah Jane Norris (1 out of 1 patent)

8.  Paul Allsop (1 out of 13 patents)

9.  Jaysukhlal Mohanlal Bhogaita (1 out of 1 patent)

10.  Andrew Ian Sapsford (1 out of 1 patent)

11.  Ian Mahaffy (1 out of 1 patent)

12.  Martin John Mcloughlin (0 patent)

13.  Martin John Mcloughlin (0 patent)


5 patents:

Company Overview
Bespak Europe Limited is a leading pharmaceutical company specializing in the development and manufacturing of advanced drug delivery devices and solutions. With a strong focus on innovation and quality, Bespak is dedicated to providing cutting-edge products that improve patient outcomes and enhance healthcare delivery. Their expertise in design, engineering, and manufacturing ensures that they deliver reliable, high-performance solutions to their customers worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#6 in Hemel Hempstead

#3,210 in United Kingdom

Hemel Hempstead, GB
Hemel Hempstead, United Kingdom
Forward Citations = 13

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bespak Europe Limited. Retrieved from https://idiyas.com/company/bespak-europe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…